• ALPROSTADIL CHEMBL495 FDA Approved

    Alternate Names:

    Prostin VR
    Vitaros
    Alprostadil
    Viridal 5
    Viridal 10
    Viridal 20
    Viridal Duo
    Prostaglandin E1
    Caverject
    Prostin
    PGE1
    Edex
    U-10136
    Prostin Vr Pediatric
    Caverject Impulse
    C28816
    135650814
    1882
    Vasoprost
    Viridal
    Vasostenoon
    Vasaprostan
    Topiglan
    Tandetron
    Sugiran
    Prostivas
    Prostin Vr Sterile Solution
    Prostavasin
    Prostandin
    Prolisina VR
    Prink
    Pridax
    Palux
    Muse
    Minprog
    Liple
    Karon
    Kaishi
    Kai Tong
    Femprox
    Eglandin
    Caverject Sterile Powder - Pws 23.2mcg/vial
    Caverject Sterile Powder - Pws 11.9mcg/vial
    Caverject Sterile Powder - Kit 23.2mcg/vial
    Caverject Sterile Powder - Kit 11.9mcg /vial
    Caverject Dual
    Caverject DC
    Cardiobron
    Bondil
    Bolesi
    Befar
    Aplicav
    Apistandin
    Alyprost
    Altesil
    Alprox-TD
    Alprostin
    Alprostar
    Alprostapint
    Alprostan
    Alprostadil Injection, USP
    Alprostadil Injection USP
    Alista
    745-65-3
    PGE1 α-CD
    PGE-1
    Alprostadil Alfadex
    11alpha,15alpha-Dihydroxy-9-oxo-13-trans-prostenoic acid
    (13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate
    (11alpha,13e,15S)-11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid
    DB00770
    ALPROSTADILUM
    SAM001246845
    L-PROSTAGLANDIN E1
    NCGC00025234-05
    A0593_SIAL
    AC1NQXHQ
    SMP2_000271
    (13E,15S)-11ALPHA,15-DIHYDROXY-9-OXOPROST-13-EN-1-OIC ACID
    AC-6095
    119314-69-1
    P5515_SIAL
    SAM001247093
    IDI1_033958
    AB00514004
    PRINK (TN)
    CPD000112594
    HMS1361K10
    ALPROSTADIL (JP15/USP/INN)
    MLS000758964
    P8908_SIGMA
    DAP000359
    NCGC00025234-04
    PROSTIN VR PEDIATRIC (TN)
    HMS1571K17
    MR 256
    LMFA03010134
    BEFAR (TN)
    HMS2052L11
    SMR000112594
    RAYVA
    7312
    PRESTWICK2_001018
    PROST-13-EN-1-OIC ACID, 11,15-DIHYDROXY-9-OXO-, (11ALPHA,13E,15S)-, HOMOPOLYMER
    HMS1791K10
    PGE1 OLIGOMER
    SAM001246840
    ALPROSTADIL PROSTOGLANDIN E1
    149351
    BSPBIO_001175
    MR-256
    NCGC00025234-02
    HEI-507
    PRESTWICK3_001018
    BIDD:GT0747
    MLS001424250
    ST50826271
    HMS2090L08
    P7527_SIGMA
    BML1-F06
    7-[(1R,2R,3R)-3-HYDROXY-2-[(E,3S)-3-HYDROXYOCT-1-ENYL]-5-OXOCYCLOPENTYL]HEPTANOIC ACID
    82474_FLUKA
    BRD-K52459643-001-06-0
    D00180
    FEMLIFE
    (11ALPHA,13E,15S)-11,15-DIHYDROXY-9-OXOPROST-13-ENOIC ACID
    CID5280723
    BSPBIO_001488
    MOLPORT-003-939-183
    HMS1989K10
    NCGC00025234-03
    C04741
    CHEBI:15544
    BPBIO1_001293
    P5515_SIGMA
    BDBM50101853
    TOX21_110482
    ZINC3813088
    HY-B0131
    HMS3648O17
    HMS3402K10
    HMS3268I09
    HMS2098K17
    (1R,2R,3R)-3-HYDROXY-2-((E)-(3S)-3-HYDROXY-1-OCTENYL)-5-OXOCYCLOPENTANEHEPTANOIC ACID
    SYN3025
    HMDB01442
    L-3-HYDROXY-2-(3-HYDROXY-1-OCTENYL)-5-OXOCYCLOPENTANEHEPTANOIC ACID
    CYCLOPENTANEHEPTANOIC ACID, 3-HYDROXY-2-(3-HYDROXY-1-OCTENYL)-5-OXO-, L-
    ALPROSTADIL (JP16/USP/INN)
    GTPL1882
    SCHEMBL33317
    DSSTOX_GSID_22578
    DSSTOX_RID_76640
    DSSTOX_CID_2578
    AI3-62116
    VITAROS (TN)
    CAS-745-65-3
    NCGC00016535-01
    NSC 165559
    PROST-13-EN-1-OIC ACID, 11,15-DIHYDROXY-9-OXO-, (11ALPHA,13E,15S)-
    LIPO-ALPROSTADIL
    EINECS 212-017-2
    ONO 1608
    PROMOSTAN
    ALPROSTADILREG
    11,15-DIHYDROXY-9-OXOPROST-13-EN-1-OIC ACID
    ALPROSTADILUM [INN-LATIN]
    L-PGE1
    7-[(1R,2R,3R)-3-HYDROXY-2-[(1E,3S)-3-HYDROXYOCT-1-EN-1-YL]-5-OXOCYCLOPENTYL]HEPTANOIC ACID
    (-)-PROTAGLANDIN E1
    7-((1R,2R,3R)-3-HYDROXY-2-((S,E)-3-HYDROXYOCT-1-EN-1-YL)-5-OXOCYCLOPENTYL)HEPTANOIC ACID
    (-)-3-HYDROXY-2-(3-HYDROXY-1-OCTENYL)-5-OXO-CYCLOPENTANEHEPTANOATE
    (+)-3-HYDROXY-2-(3-HYDROXY-1-OCTENYL)-5-OXO-CYCLOPENTANEHEPTANOATE
    3-HYDROXY-2-(3-HYDROXY-1-OCTENYL)-5-OXO-CYCLOPENTANEHEPTANOATE
    11,15-DIHYDROXY-9-OXOPROST-13-EN-1-OIC ACID (ACD/NAME 4.0)
    (13E)-(15S)-11ALPHA,15-DIHYDROXY-9-OXOPROST-13-ENOIC ACID
    (13E)-(15S)-11-ALPHA,15-DIHYDROXY-9-OXOPROST-13-ENOIC ACID
    (13E)-(15S)-11-ALPHA,15-DIHYDROXY-9-OXOPROST-13-ENOATE
    (13E)-(15S)-11,15-DIHYDROXY-9-OXOPROST-13-ENOIC ACID
    (13E)-(15S)-11,15-DIHYDROXY-9-OXOPROST-13-ENOATE
    LIPROSTIN
    LIPOPROST
    9-OXO-11R,15S-DIHYDROXY-13E-PROSTAENOIC ACID
    11,15-DIHYDROXY-9-OXOPROST-13-EN-1-OATE
    GMVPRGQOIOIIMI-DWKJAMRDSA-N
    UNII-F5TD010360
    ALPROSTADIL(USAN)
    PROSTAGLANDINE E
    5280723
    XPG
    7-[5-((1E)(3S)-3-HYDROXYOCT-1-ENYL)(1R,4R,5R)-4-HYDROXY-2-OXOCYCLOPENTYL]HEPTA NOIC ACID
    50865-30-0
    50-83-9
    22299-37-2
    PROST-13-EN-1-OIC ACID, 11,15-DIHYDROXY-9-OXO-, (11.ALPHA.,13E,15S)-
    CYCLOPENTANEHEPTANOIC ACID, 3-HYDROXY-2-(3-HYDROXY-1-OCTENYL)-5-OXO-, (-)-
    7-[(1R,3R)-3-HYDROXY-2-[(1E,3S)-3-HYDROXYOCT-1-EN-1-YL]-5-OXOCYCLOPENTYL]HEPTANOIC ACID
    (11?,13E,15S)-11,15-DIHYDROXY-9-OXO-PROST-13-EN-1-OIC ACID
    W-104416
    3B2-6027
    AB00514004-08
    AB00514004-06
    PROSTAGLANDIN E1;EDEX;MUSE;LIPROSTIN;CAVERJECT
    FT-0603510
    AB2000131
    AB0014134
    LP069786
    K274
    DR001827
    BC205461
    ALPROSTADIL [USAN:USP:INN:BAN:JAN]
    RP17688
    NC00438
    F5TD010360
    CS-1905
    CCG-101188
    BCP9000277
    AKOS015961103
    DAP001490
    LIPOSOMAL PROSTAGLANDIN E1
    DB05391
    7-[(1R,2R,3R)-3-HYDROXY-2-[(3S)-3-HYDROXYOCT-1-ENYL]-5-OXOCYCLOPENTYL]HEPTANOIC ACID
    BRD-K48099440-001-01-7
    BIO2_000688
    BIO2_000208
    BIO1_001207
    BIO1_000718
    BIO1_000229
    KBIO3_000416
    KBIO3_000415
    KBIO2_005344
    KBIO2_002776
    KBIO2_000208
    SCHEMBL2962928
    SPBIO_003046
    KBIOSS_000208
    KBIOGR_000208
    CBIOL_001943
    PRESTWICK1_001018
    PRESTWICK0_001018
    AC1L3YXT
    PGE1 ALPHA-CD
    CYCLOPENTANEHEPTANOIC ACID, 3-HYDROXY-2-(3-HYDROXY-1-OCTENYL)-5-OXO-, (+)-
    7-[(1R,3R)-3-HYDROXY-2-[(E,3S)-3-HYDROXYOCT-1-ENYL]-5-OXOCYCLOPENTYL]HEPTANOIC ACID
    7-[(1R,3R)-3-HYDROXY-2-[(E,3S)-3-HYDROXYOCT-1-ENYL]-5-OXO-CYCLOPENTYL]HEPTANOIC ACID
    LS-58016
    PDSP2_001567
    ALPROSTADIL [USAN:INN:BAN:JAN]
    SCHEMBL10198573
    AC1O5FT0
    PROSTAGLANDIN E1ALPHA
    PGE1ALPHA
    CAVEJECT
    6433212
    LIPO-PGE1
    VAZAPROSTAN
    48415538
    PGE₁

    Drug Info:

    Drug Categories vasodilator agents
    Drug Categories urologicals
    Drug Categories urological agents
    Drug Categories therapeutic uses
    Drug Categories prostaglandins e
    Drug Categories prostaglandins
    Drug Categories platelet aggregation inhibitors
    Drug Categories pharmacologic actions
    Drug Categories lipids
    Drug Categories inflammation mediators
    Drug Categories hematologic agents
    Drug Categories genito urinary system and sex hormones
    Drug Categories fatty acids, unsaturated
    Drug Categories fatty acids, monounsaturated
    Drug Categories fatty acids
    Drug Categories eicosanoids
    Drug Categories drugs used in erectile dysfunction
    Drug Categories chemical actions and uses
    Drug Categories cardiovascular agents
    Drug Categories biological factors
    Drug Categories autacoids
    Drug Groups investigational
    Drug Groups approved
    Drug Type small molecule
    Year of Approval 1995
    Drug Class anti-impotence agents
    Drug Categories N/A
    FDA Approval approved
    Drug Class Small Molecule
    Drug Indications for treatment of erectile dysfunction,for treatment of sexual dysfunction in women
    (7 More Sources)